Independent analysis and perspectives on regulatory strategy, quality systems, clinical operations, and governance shaping the pharma and life-sciences sector in South Africa and across Africa.
Inspection readiness has become one of the most critical success factors for pharmaceutical, biotech, and medical device companies in South Africa. With the South African Health Products Regulatory Authority (SAHPRA) increasing its inspection activities and global sponsors demanding rigorous compliance…
South Africa’s pharmaceutical and clinical research sector has grown rapidly over the last decade. The country now supports large-scale clinical trials, vaccine manufacturing, and supply of critical medicines across sub-Saharan Africa. With this growth, however, comes increased regulatory scrutiny. The…
Introduction South Africa’s medical device and diagnostics sector is expanding rapidly. From local innovators developing diagnostic kits to multinationals manufacturing implantable devices, the industry plays a vital role in patient care and economic growth. But with growth comes scrutiny. Regulators,…
Data integrity has become one of the most scrutinised areas in pharmaceutical manufacturing and clinical research inspections globally. In South Africa, regulators such as the South African Health Products Regulatory Authority (SAHPRA), together with international sponsors and donors, increasingly focus…
Introduction South Africa’s pharmaceutical industry is a critical hub for supplying medicines across the country and the wider sub-Saharan Africa region. From antiretrovirals and vaccines to investigational trial products, millions of patients depend on safe, effective, and timely delivery. But…
The International Council for Harmonisation (ICH) guidelines represent the global benchmark for the design, conduct, monitoring, and reporting of clinical trials. For South Africa, where clinical research plays a critical role in public health, scientific advancement, and economic development, adherence…
South Africa has become one of the most active clinical trial hubs in Africa, with studies ranging from HIV prevention and tuberculosis vaccines to oncology and rare diseases. International sponsors, including the U.S. National Institutes of Health (NIH), the Bill…
South Africa has emerged as one of the most important clinical research destinations in Africa. With a high burden of diseases such as HIV, tuberculosis, cancer, and cardiovascular conditions, the country offers access to diverse patient populations that are essential…
South Africa is one of Africa’s largest and most established hubs for clinical research, hosting hundreds of active trials across HIV, tuberculosis, oncology, vaccines, and emerging therapeutic areas. These studies are frequently funded by international sponsors such as the National…
A Regulatory Interpretation of Scope, Classification, and Compliance Obligations Table of Contents 1. Introduction: Why Regulatory Distinction Matters in South Africa 2. South Africa’s Regulatory Architecture for Health Products 3. Legal Definitions Under South African Law 3.1 What Constitutes a…